APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parenteral Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Parenteral Drugs Market Analysis and Forecast 2026-2032

20 December 2025212 pages

Choose your research edition.

Industry ResearchParenteral Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral Drugs Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Parenteral Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral Drugs Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral Drugs Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Parenteral Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Parenteral Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Parenteral Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Parenteral Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Parenteral Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Parenteral Drugs include Albert David, Aspen Holdings, AXA Parenterals Ltd, BAG Healthcare, Baxter Healthcare Corporation, Beximco Pharma, BML Parenteral Drugs, Cook Pharmica and Ostuka Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Parenteral Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Parenteral Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Parenteral Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Parenteral Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Parenteral Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Parenteral Drugs sales, projected growth trends, production technology, application and end-user industry.

Parenteral Drugs Segment by Company

Albert David

Aspen Holdings

AXA Parenterals Ltd

BAG Healthcare

Baxter Healthcare Corporation

Beximco Pharma

BML Parenteral Drugs

Cook Pharmica

Ostuka Pharmaceutical

Ozon Pharmaceuticals Ltd

Patheon

PSI Ltd

Southwest Pharmaceutical

B. Braun

Cisen

Fresenius

Pfizer (Hospira)

Kelun Pharma

Acebright

SSY Group

Teva Pharmaceutical Industries

Abbott

Parenteral Drugs Segment by Type

LVP Drug

SVP Drug

Parenteral Drugs Segment by Application

Hospitals

Medical Centers

Others

Parenteral Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Parenteral Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Parenteral Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parenteral Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Parenteral Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. LVP Drug Major Manufacturers Table 3. SVP Drug Major Manufacturers Table 4. Global Parenteral Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Medical Centers Major Manufacturers Table 7. Others Major Manufacturers Table 8. Parenteral Drugs Industry Trends Table 9. Parenteral Drugs Industry Drivers Table 10. Parenteral Drugs Industry Opportunities and Challenges Table 11. Parenteral Drugs Industry Restraints Table 12. Global Parenteral Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Parenteral Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Parenteral Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Parenteral Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Parenteral Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Parenteral Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Parenteral Drugs Sales by Region (2021-2026) & (k units) Table 19. Global Parenteral Drugs Sales by Region (2027-2032) & (k units) Table 20. Global Parenteral Drugs Sales Market Share by Region (2021-2026) Table 21. Global Parenteral Drugs Sales Market Share by Region (2027-2032) Table 22. Global Parenteral Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Parenteral Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Parenteral Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Parenteral Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Parenteral Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Parenteral Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Parenteral Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Parenteral Drugs Manufacturers, Product Type & Application Table 30. Global Parenteral Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Parenteral Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Parenteral Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Parenteral Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Parenteral Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Parenteral Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Parenteral Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Parenteral Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Parenteral Drugs Sales by Type (2021-2026) & (k units) Table 40. Global Parenteral Drugs Sales by Type (2027-2032) & (k units) Table 41. Global Parenteral Drugs Sales Market Share by Type (2021-2026) Table 42. Global Parenteral Drugs Sales Market Share by Type (2027-2032) Table 43. Global Parenteral Drugs Price by Type (2021-2026) & (US$/unit) Table 44. Global Parenteral Drugs Price by Type (2027-2032) & (US$/unit) Table 45. Global Parenteral Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Parenteral Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Parenteral Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Parenteral Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Parenteral Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Parenteral Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Parenteral Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Parenteral Drugs Sales by Application (2027-2032) & (k units) Table 53. Global Parenteral Drugs Sales Market Share by Application (2021-2026) Table 54. Global Parenteral Drugs Sales Market Share by Application (2027-2032) Table 55. Global Parenteral Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Parenteral Drugs Price by Application (2027-2032) & (US$/unit) Table 57. Albert David Company Information Table 58. Albert David Business Overview Table 59. Albert David Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Albert David Parenteral Drugs Product Portfolio Table 61. Albert David Recent Development Table 62. Aspen Holdings Company Information Table 63. Aspen Holdings Business Overview Table 64. Aspen Holdings Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Aspen Holdings Parenteral Drugs Product Portfolio Table 66. Aspen Holdings Recent Development Table 67. AXA Parenterals Ltd Company Information Table 68. AXA Parenterals Ltd Business Overview Table 69. AXA Parenterals Ltd Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. AXA Parenterals Ltd Parenteral Drugs Product Portfolio Table 71. AXA Parenterals Ltd Recent Development Table 72. BAG Healthcare Company Information Table 73. BAG Healthcare Business Overview Table 74. BAG Healthcare Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. BAG Healthcare Parenteral Drugs Product Portfolio Table 76. BAG Healthcare Recent Development Table 77. Baxter Healthcare Corporation Company Information Table 78. Baxter Healthcare Corporation Business Overview Table 79. Baxter Healthcare Corporation Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Baxter Healthcare Corporation Parenteral Drugs Product Portfolio Table 81. Baxter Healthcare Corporation Recent Development Table 82. Beximco Pharma Company Information Table 83. Beximco Pharma Business Overview Table 84. Beximco Pharma Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Beximco Pharma Parenteral Drugs Product Portfolio Table 86. Beximco Pharma Recent Development Table 87. BML Parenteral Drugs Company Information Table 88. BML Parenteral Drugs Business Overview Table 89. BML Parenteral Drugs Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. BML Parenteral Drugs Parenteral Drugs Product Portfolio Table 91. BML Parenteral Drugs Recent Development Table 92. Cook Pharmica Company Information Table 93. Cook Pharmica Business Overview Table 94. Cook Pharmica Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Cook Pharmica Parenteral Drugs Product Portfolio Table 96. Cook Pharmica Recent Development Table 97. Ostuka Pharmaceutical Company Information Table 98. Ostuka Pharmaceutical Business Overview Table 99. Ostuka Pharmaceutical Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Ostuka Pharmaceutical Parenteral Drugs Product Portfolio Table 101. Ostuka Pharmaceutical Recent Development Table 102. Ozon Pharmaceuticals Ltd Company Information Table 103. Ozon Pharmaceuticals Ltd Business Overview Table 104. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Portfolio Table 106. Ozon Pharmaceuticals Ltd Recent Development Table 107. Patheon Company Information Table 108. Patheon Business Overview Table 109. Patheon Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Patheon Parenteral Drugs Product Portfolio Table 111. Patheon Recent Development Table 112. PSI Ltd Company Information Table 113. PSI Ltd Business Overview Table 114. PSI Ltd Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. PSI Ltd Parenteral Drugs Product Portfolio Table 116. PSI Ltd Recent Development Table 117. Southwest Pharmaceutical Company Information Table 118. Southwest Pharmaceutical Business Overview Table 119. Southwest Pharmaceutical Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Southwest Pharmaceutical Parenteral Drugs Product Portfolio Table 121. Southwest Pharmaceutical Recent Development Table 122. B. Braun Company Information Table 123. B. Braun Business Overview Table 124. B. Braun Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. B. Braun Parenteral Drugs Product Portfolio Table 126. B. Braun Recent Development Table 127. Cisen Company Information Table 128. Cisen Business Overview Table 129. Cisen Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Cisen Parenteral Drugs Product Portfolio Table 131. Cisen Recent Development Table 132. Fresenius Company Information Table 133. Fresenius Business Overview Table 134. Fresenius Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Fresenius Parenteral Drugs Product Portfolio Table 136. Fresenius Recent Development Table 137. Pfizer (Hospira) Company Information Table 138. Pfizer (Hospira) Business Overview Table 139. Pfizer (Hospira) Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Pfizer (Hospira) Parenteral Drugs Product Portfolio Table 141. Pfizer (Hospira) Recent Development Table 142. Kelun Pharma Company Information Table 143. Kelun Pharma Business Overview Table 144. Kelun Pharma Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Kelun Pharma Parenteral Drugs Product Portfolio Table 146. Kelun Pharma Recent Development Table 147. Acebright Company Information Table 148. Acebright Business Overview Table 149. Acebright Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 150. Acebright Parenteral Drugs Product Portfolio Table 151. Acebright Recent Development Table 152. SSY Group Company Information Table 153. SSY Group Business Overview Table 154. SSY Group Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 155. SSY Group Parenteral Drugs Product Portfolio Table 156. SSY Group Recent Development Table 157. Teva Pharmaceutical Industries Company Information Table 158. Teva Pharmaceutical Industries Business Overview Table 159. Teva Pharmaceutical Industries Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 160. Teva Pharmaceutical Industries Parenteral Drugs Product Portfolio Table 161. Teva Pharmaceutical Industries Recent Development Table 162. Abbott Company Information Table 163. Abbott Business Overview Table 164. Abbott Parenteral Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 165. Abbott Parenteral Drugs Product Portfolio Table 166. Abbott Recent Development Table 167. North America Parenteral Drugs Revenue by Type (2021-2026) & (US$ Million) Table 168. North America Parenteral Drugs Revenue by Type (2027-2032) & (US$ Million) Table 169. North America Parenteral Drugs Sales by Type (2021-2026) & (k units) Table 170. North America Parenteral Drugs Sales by Type (2027-2032) & (k units) Table 171. North America Parenteral Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 172. North America Parenteral Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 173. North America Parenteral Drugs Revenue by Application (2021-2026) & (US$ Million) Table 174. North America Parenteral Drugs Revenue by Application (2027-2032) & (US$ Million) Table 175. North America Parenteral Drugs Sales by Application (2021-2026) & (k units) Table 176. North America Parenteral Drugs Sales by Application (2027-2032) & (k units) Table 177. North America Parenteral Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 178. North America Parenteral Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 179. North America Parenteral Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. North America Parenteral Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. North America Parenteral Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. North America Parenteral Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 183. North America Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 184. North America Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 185. North America Parenteral Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 186. North America Parenteral Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 187. United States Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 188. Canada Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 189. Mexico Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 190. Europe Parenteral Drugs Revenue by Type (2021-2026) & (US$ Million) Table 191. Europe Parenteral Drugs Revenue by Type (2027-2032) & (US$ Million) Table 192. Europe Parenteral Drugs Sales by Type (2021-2026) & (k units) Table 193. Europe Parenteral Drugs Sales by Type (2027-2032) & (k units) Table 194. Europe Parenteral Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 195. Europe Parenteral Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 196. Europe Parenteral Drugs Revenue by Application (2021-2026) & (US$ Million) Table 197. Europe Parenteral Drugs Revenue by Application (2027-2032) & (US$ Million) Table 198. Europe Parenteral Drugs Sales by Application (2021-2026) & (k units) Table 199. Europe Parenteral Drugs Sales by Application (2027-2032) & (k units) Table 200. Europe Parenteral Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 201. Europe Parenteral Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 202. Europe Parenteral Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. Europe Parenteral Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. Europe Parenteral Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. Europe Parenteral Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 206. Europe Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 207. Europe Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 208. Europe Parenteral Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 209. Europe Parenteral Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 210. Germany Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 211. France Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 212. U.K. Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 213. Italy Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 214. Russia Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 215. Spain Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 216. Netherlands Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 217. Switzerland Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 218. Sweden Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 219. Poland Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 220. China Parenteral Drugs Revenue by Type (2021-2026) & (US$ Million) Table 221. China Parenteral Drugs Revenue by Type (2027-2032) & (US$ Million) Table 222. China Parenteral Drugs Sales by Type (2021-2026) & (k units) Table 223. China Parenteral Drugs Sales by Type (2027-2032) & (k units) Table 224. China Parenteral Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 225. China Parenteral Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 226. China Parenteral Drugs Revenue by Application (2021-2026) & (US$ Million) Table 227. China Parenteral Drugs Revenue by Application (2027-2032) & (US$ Million) Table 228. China Parenteral Drugs Sales by Application (2021-2026) & (k units) Table 229. China Parenteral Drugs Sales by Application (2027-2032) & (k units) Table 230. China Parenteral Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 231. China Parenteral Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 232. Asia Parenteral Drugs Revenue by Type (2021-2026) & (US$ Million) Table 233. Asia Parenteral Drugs Revenue by Type (2027-2032) & (US$ Million) Table 234. Asia Parenteral Drugs Sales by Type (2021-2026) & (k units) Table 235. Asia Parenteral Drugs Sales by Type (2027-2032) & (k units) Table 236. Asia Parenteral Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 237. Asia Parenteral Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 238. Asia Parenteral Drugs Revenue by Application (2021-2026) & (US$ Million) Table 239. Asia Parenteral Drugs Revenue by Application (2027-2032) & (US$ Million) Table 240. Asia Parenteral Drugs Sales by Application (2021-2026) & (k units) Table 241. Asia Parenteral Drugs Sales by Application (2027-2032) & (k units) Table 242. Asia Parenteral Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 243. Asia Parenteral Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 244. Asia Parenteral Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. Asia Parenteral Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. Asia Parenteral Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. Asia Parenteral Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 248. Asia Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 249. Asia Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 250. Asia Parenteral Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 251. Asia Parenteral Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 252. Japan Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 253. South Korea Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 254. India Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 255. Australia Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 256. Taiwan Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 257. Southeast Asia Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 258. SAMEA Parenteral Drugs Revenue by Type (2021-2026) & (US$ Million) Table 259. SAMEA Parenteral Drugs Revenue by Type (2027-2032) & (US$ Million) Table 260. SAMEA Parenteral Drugs Sales by Type (2021-2026) & (k units) Table 261. SAMEA Parenteral Drugs Sales by Type (2027-2032) & (k units) Table 262. SAMEA Parenteral Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 263. SAMEA Parenteral Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 264. SAMEA Parenteral Drugs Revenue by Application (2021-2026) & (US$ Million) Table 265. SAMEA Parenteral Drugs Revenue by Application (2027-2032) & (US$ Million) Table 266. SAMEA Parenteral Drugs Sales by Application (2021-2026) & (k units) Table 267. SAMEA Parenteral Drugs Sales by Application (2027-2032) & (k units) Table 268. SAMEA Parenteral Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 269. SAMEA Parenteral Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 270. SAMEA Parenteral Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 271. SAMEA Parenteral Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 272. SAMEA Parenteral Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 273. SAMEA Parenteral Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 274. SAMEA Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 275. SAMEA Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 276. SAMEA Parenteral Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 277. SAMEA Parenteral Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 278. Brazil Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 279. Argentina Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 280. Chile Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 281. Colombia Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 282. Peru Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 283. Saudi Arabia Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 284. Israel Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 285. UAE Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 286. Turkey Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 287. Iran Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 288. Egypt Parenteral Drugs Revenue (2021-2032) & (US$ Million) Table 289. Key Raw Materials Table 290. Raw Materials Key Suppliers Table 291. Parenteral Drugs Distributors List Table 292. Parenteral Drugs Customers List Table 293. Research Programs/Design for This Report Table 294. Authors List of This Report Table 295. Secondary Sources Table 296. Primary Sources List of Figures Figure 1. Parenteral Drugs Image Figure 2. Global Parenteral Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. LVP Drug Image Figure 5. SVP Drug Image Figure 6. Global Parenteral Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Parenteral Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Medical Centers Image Figure 10. Others Image Figure 11. Global Parenteral Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Parenteral Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Parenteral Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Parenteral Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Parenteral Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Parenteral Drugs Sales (2021-2032) & (k units) Figure 17. Global Parenteral Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Parenteral Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Parenteral Drugs Sales YoY (2021-2032) & (k units) Figure 20. Europe Parenteral Drugs Sales YoY (2021-2032) & (k units) Figure 21. China Parenteral Drugs Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Parenteral Drugs Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Parenteral Drugs Sales YoY (2021-2032) & (k units) Figure 24. Global Parenteral Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Parenteral Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Parenteral Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Parenteral Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Parenteral Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Parenteral Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Parenteral Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Parenteral Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Parenteral Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Parenteral Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Parenteral Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Parenteral Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Parenteral Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Parenteral Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Parenteral Drugs Revenue Share by Type (2021-2032) Figure 40. North America Parenteral Drugs Sales Share by Type (2021-2032) Figure 41. North America Parenteral Drugs Revenue Share by Application (2021-2032) Figure 42. North America Parenteral Drugs Sales Share by Application (2021-2032) Figure 43. North America Parenteral Drugs Revenue Share by Country (2021-2032) Figure 44. North America Parenteral Drugs Sales Share by Country (2021-2032) Figure 45. Europe Parenteral Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Parenteral Drugs Sales Share by Type (2021-2032) Figure 47. Europe Parenteral Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Parenteral Drugs Sales Share by Application (2021-2032) Figure 49. Europe Parenteral Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Parenteral Drugs Sales Share by Country (2021-2032) Figure 51. China Parenteral Drugs Revenue Share by Type (2021-2032) Figure 52. China Parenteral Drugs Sales Share by Type (2021-2032) Figure 53. China Parenteral Drugs Revenue Share by Application (2021-2032) Figure 54. China Parenteral Drugs Sales Share by Application (2021-2032) Figure 55. Asia Parenteral Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Parenteral Drugs Sales Share by Type (2021-2032) Figure 57. Asia Parenteral Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Parenteral Drugs Sales Share by Application (2021-2032) Figure 59. Asia Parenteral Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Parenteral Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Parenteral Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Parenteral Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Parenteral Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Parenteral Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Parenteral Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Parenteral Drugs Sales Share by Country (2021-2032) Figure 67. Parenteral Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Parenteral Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • LVP Drug
  • SVP Drug
Applications
  • Hospitals
  • Medical Centers
  • Others
Companies covered
  • Albert David
  • Aspen Holdings
  • AXA Parenterals Ltd
  • BAG Healthcare
  • Baxter Healthcare Corporation
  • Beximco Pharma
  • BML Parenteral Drugs
  • Cook Pharmica
  • Ostuka Pharmaceutical
  • Ozon Pharmaceuticals Ltd
  • Patheon
  • PSI Ltd
  • Southwest Pharmaceutical
  • B. Braun
  • Cisen
  • Fresenius
  • Pfizer (Hospira)
  • Kelun Pharma
  • Acebright
  • SSY Group
  • Teva Pharmaceutical Industries
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Parenteral Drugs Market by Type
  3. 1.2.1 Global Parenteral Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 LVP Drug
  5. 1.2.3 SVP Drug
  6. 1.3 Parenteral Drugs Market by Application
  7. 1.3.1 Global Parenteral Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Medical Centers
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Parenteral Drugs Market Dynamics
  1. 2.1 Parenteral Drugs Industry Trends
  2. 2.2 Parenteral Drugs Industry Drivers
  3. 2.3 Parenteral Drugs Industry Opportunities and Challenges
  4. 2.4 Parenteral Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Parenteral Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Parenteral Drugs Revenue by Region
  3. 3.2.1 Global Parenteral Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Parenteral Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Parenteral Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Parenteral Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Parenteral Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Parenteral Drugs Sales by Region
  9. 3.4.1 Global Parenteral Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Parenteral Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Parenteral Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Parenteral Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Parenteral Drugs Revenue by Manufacturers
  2. 4.1.1 Global Parenteral Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Parenteral Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Parenteral Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Parenteral Drugs Sales by Manufacturers
  6. 4.2.1 Global Parenteral Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Parenteral Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Parenteral Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Parenteral Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Parenteral Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Parenteral Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Parenteral Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Parenteral Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Parenteral Drugs Market CR5 and HHI
  16. 4.8.2 2025 Parenteral Drugs Tier 1, Tier 2, and Tier 3
5 Parenteral Drugs Market by Type
  1. 5.1 Global Parenteral Drugs Revenue by Type
  2. 5.1.1 Global Parenteral Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Parenteral Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Parenteral Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Parenteral Drugs Sales by Type
  6. 5.2.1 Global Parenteral Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Parenteral Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Parenteral Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Parenteral Drugs Price by Type
6 Parenteral Drugs Market by Application
  1. 6.1 Global Parenteral Drugs Revenue by Application
  2. 6.1.1 Global Parenteral Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Parenteral Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Parenteral Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Parenteral Drugs Sales by Application
  6. 6.2.1 Global Parenteral Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Parenteral Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Parenteral Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Parenteral Drugs Price by Application
7 Company Profiles
  1. 7.1 Albert David
  2. 7.1.1 Albert David Company Information
  3. 7.1.2 Albert David Business Overview
  4. 7.1.3 Albert David Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Albert David Parenteral Drugs Product Portfolio
  6. 7.1.5 Albert David Recent Developments
  7. 7.2 Aspen Holdings
  8. 7.2.1 Aspen Holdings Company Information
  9. 7.2.2 Aspen Holdings Business Overview
  10. 7.2.3 Aspen Holdings Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aspen Holdings Parenteral Drugs Product Portfolio
  12. 7.2.5 Aspen Holdings Recent Developments
  13. 7.3 AXA Parenterals Ltd
  14. 7.3.1 AXA Parenterals Ltd Company Information
  15. 7.3.2 AXA Parenterals Ltd Business Overview
  16. 7.3.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AXA Parenterals Ltd Parenteral Drugs Product Portfolio
  18. 7.3.5 AXA Parenterals Ltd Recent Developments
  19. 7.4 BAG Healthcare
  20. 7.4.1 BAG Healthcare Company Information
  21. 7.4.2 BAG Healthcare Business Overview
  22. 7.4.3 BAG Healthcare Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 BAG Healthcare Parenteral Drugs Product Portfolio
  24. 7.4.5 BAG Healthcare Recent Developments
  25. 7.5 Baxter Healthcare Corporation
  26. 7.5.1 Baxter Healthcare Corporation Company Information
  27. 7.5.2 Baxter Healthcare Corporation Business Overview
  28. 7.5.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Baxter Healthcare Corporation Parenteral Drugs Product Portfolio
  30. 7.5.5 Baxter Healthcare Corporation Recent Developments
  31. 7.6 Beximco Pharma
  32. 7.6.1 Beximco Pharma Company Information
  33. 7.6.2 Beximco Pharma Business Overview
  34. 7.6.3 Beximco Pharma Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Beximco Pharma Parenteral Drugs Product Portfolio
  36. 7.6.5 Beximco Pharma Recent Developments
  37. 7.7 BML Parenteral Drugs
  38. 7.7.1 BML Parenteral Drugs Company Information
  39. 7.7.2 BML Parenteral Drugs Business Overview
  40. 7.7.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 BML Parenteral Drugs Parenteral Drugs Product Portfolio
  42. 7.7.5 BML Parenteral Drugs Recent Developments
  43. 7.8 Cook Pharmica
  44. 7.8.1 Cook Pharmica Company Information
  45. 7.8.2 Cook Pharmica Business Overview
  46. 7.8.3 Cook Pharmica Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Cook Pharmica Parenteral Drugs Product Portfolio
  48. 7.8.5 Cook Pharmica Recent Developments
  49. 7.9 Ostuka Pharmaceutical
  50. 7.9.1 Ostuka Pharmaceutical Company Information
  51. 7.9.2 Ostuka Pharmaceutical Business Overview
  52. 7.9.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ostuka Pharmaceutical Parenteral Drugs Product Portfolio
  54. 7.9.5 Ostuka Pharmaceutical Recent Developments
  55. 7.10 Ozon Pharmaceuticals Ltd
  56. 7.10.1 Ozon Pharmaceuticals Ltd Company Information
  57. 7.10.2 Ozon Pharmaceuticals Ltd Business Overview
  58. 7.10.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Portfolio
  60. 7.10.5 Ozon Pharmaceuticals Ltd Recent Developments
  61. 7.11 Patheon
  62. 7.11.1 Patheon Company Information
  63. 7.11.2 Patheon Business Overview
  64. 7.11.3 Patheon Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Patheon Parenteral Drugs Product Portfolio
  66. 7.11.5 Patheon Recent Developments
  67. 7.12 PSI Ltd
  68. 7.12.1 PSI Ltd Company Information
  69. 7.12.2 PSI Ltd Business Overview
  70. 7.12.3 PSI Ltd Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 PSI Ltd Parenteral Drugs Product Portfolio
  72. 7.12.5 PSI Ltd Recent Developments
  73. 7.13 Southwest Pharmaceutical
  74. 7.13.1 Southwest Pharmaceutical Company Information
  75. 7.13.2 Southwest Pharmaceutical Business Overview
  76. 7.13.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Southwest Pharmaceutical Parenteral Drugs Product Portfolio
  78. 7.13.5 Southwest Pharmaceutical Recent Developments
  79. 7.14 B. Braun
  80. 7.14.1 B. Braun Company Information
  81. 7.14.2 B. Braun Business Overview
  82. 7.14.3 B. Braun Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 B. Braun Parenteral Drugs Product Portfolio
  84. 7.14.5 B. Braun Recent Developments
  85. 7.15 Cisen
  86. 7.15.1 Cisen Company Information
  87. 7.15.2 Cisen Business Overview
  88. 7.15.3 Cisen Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Cisen Parenteral Drugs Product Portfolio
  90. 7.15.5 Cisen Recent Developments
  91. 7.16 Fresenius
  92. 7.16.1 Fresenius Company Information
  93. 7.16.2 Fresenius Business Overview
  94. 7.16.3 Fresenius Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Fresenius Parenteral Drugs Product Portfolio
  96. 7.16.5 Fresenius Recent Developments
  97. 7.17 Pfizer (Hospira)
  98. 7.17.1 Pfizer (Hospira) Company Information
  99. 7.17.2 Pfizer (Hospira) Business Overview
  100. 7.17.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Pfizer (Hospira) Parenteral Drugs Product Portfolio
  102. 7.17.5 Pfizer (Hospira) Recent Developments
  103. 7.18 Kelun Pharma
  104. 7.18.1 Kelun Pharma Company Information
  105. 7.18.2 Kelun Pharma Business Overview
  106. 7.18.3 Kelun Pharma Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Kelun Pharma Parenteral Drugs Product Portfolio
  108. 7.18.5 Kelun Pharma Recent Developments
  109. 7.19 Acebright
  110. 7.19.1 Acebright Company Information
  111. 7.19.2 Acebright Business Overview
  112. 7.19.3 Acebright Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Acebright Parenteral Drugs Product Portfolio
  114. 7.19.5 Acebright Recent Developments
  115. 7.20 SSY Group
  116. 7.20.1 SSY Group Company Information
  117. 7.20.2 SSY Group Business Overview
  118. 7.20.3 SSY Group Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 SSY Group Parenteral Drugs Product Portfolio
  120. 7.20.5 SSY Group Recent Developments
  121. 7.21 Teva Pharmaceutical Industries
  122. 7.21.1 Teva Pharmaceutical Industries Company Information
  123. 7.21.2 Teva Pharmaceutical Industries Business Overview
  124. 7.21.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Teva Pharmaceutical Industries Parenteral Drugs Product Portfolio
  126. 7.21.5 Teva Pharmaceutical Industries Recent Developments
  127. 7.22 Abbott
  128. 7.22.1 Abbott Company Information
  129. 7.22.2 Abbott Business Overview
  130. 7.22.3 Abbott Parenteral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Abbott Parenteral Drugs Product Portfolio
  132. 7.22.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Parenteral Drugs Market Size by Type
  2. 8.1.1 North America Parenteral Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Parenteral Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Parenteral Drugs Price by Type (2021-2032)
  5. 8.2 North America Parenteral Drugs Market Size by Application
  6. 8.2.1 North America Parenteral Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Parenteral Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Parenteral Drugs Price by Application (2021-2032)
  9. 8.3 North America Parenteral Drugs Market Size by Country
  10. 8.3.1 North America Parenteral Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Parenteral Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Parenteral Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Parenteral Drugs Market Size by Type
  2. 9.1.1 Europe Parenteral Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Parenteral Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Parenteral Drugs Price by Type (2021-2032)
  5. 9.2 Europe Parenteral Drugs Market Size by Application
  6. 9.2.1 Europe Parenteral Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Parenteral Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Parenteral Drugs Price by Application (2021-2032)
  9. 9.3 Europe Parenteral Drugs Market Size by Country
  10. 9.3.1 Europe Parenteral Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Parenteral Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Parenteral Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Parenteral Drugs Market Size by Type
  2. 10.1.1 China Parenteral Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Parenteral Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Parenteral Drugs Price by Type (2021-2032)
  5. 10.2 China Parenteral Drugs Market Size by Application
  6. 10.2.1 China Parenteral Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Parenteral Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Parenteral Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Parenteral Drugs Market Size by Type
  2. 11.1.1 Asia Parenteral Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Parenteral Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Parenteral Drugs Price by Type (2021-2032)
  5. 11.2 Asia Parenteral Drugs Market Size by Application
  6. 11.2.1 Asia Parenteral Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Parenteral Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Parenteral Drugs Price by Application (2021-2032)
  9. 11.3 Asia Parenteral Drugs Market Size by Country
  10. 11.3.1 Asia Parenteral Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Parenteral Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Parenteral Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Parenteral Drugs Market Size by Type
  2. 12.1.1 SAMEA Parenteral Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Parenteral Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Parenteral Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Parenteral Drugs Market Size by Application
  6. 12.2.1 SAMEA Parenteral Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Parenteral Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Parenteral Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Parenteral Drugs Market Size by Country
  10. 12.3.1 SAMEA Parenteral Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Parenteral Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Parenteral Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Parenteral Drugs Value Chain Analysis
  2. 13.1.1 Parenteral Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Parenteral Drugs Production Mode & Process
  6. 13.2 Parenteral Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Parenteral Drugs Distributors
  9. 13.2.3 Parenteral Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst